Compare Allstate Corp (ALL) vs BioNTech SE - ADR (BNTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Allstate Corp vs BioNTech SE - ADR — how do they compare? Allstate Corp trades at $262 (market cap $66.31B), while BioNTech SE - ADR trades at $92.8 (market cap $23.31B). The key difference: Allstate Corp is far larger — about 2.8× BioNTech SE - ADR's market cap, and Allstate Corp pays a 1.65% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| ALL | BNTX | |
|---|---|---|
Market Cap | $66.31B | $23.31B |
Sector | Financials | Health |
52-Week High | $275.11 | $119.34 |
52-Week Low | $190.00 | $83.89 |
Enterprise Value | $74.96B | $6.60B |
Dividend Yield | 1.65% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Allstate Corp
On the basis of premium sales, Allstate is one of the largest U.S. property and casualty insurers. Personal auto represents the largest percentage of revenue, but the company offers homeowners insurance and other insurance products. Allstate products are sold in North America primarily by about 10,000 agencies.
Read more on ALL →About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →
